Effects of D-myo-inositol-1,2,6-trisphosphate on eicosanoid formation in burned skin

Journal of Surgical Research

Volumn 62, Issue 1, 1996, Pages 1-4

  Tarnow, P ^a   Cassuto, J ^a   Jonsson A ^a   Nellgard P ^a   Bennett, A ^b   Tavares, I A ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; INOSITOL 1,2,6 TRISPHOSPHATE; LEUKOTRIENE B4; PROSTAGLANDIN E; THROMBOXANE B2;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; BURN; CONTROLLED STUDY; ICOSANOID METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; SKIN EDEMA;

EID: 0029923445     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0163     Document Type: Article

References (31)

1. Cassuto, J., Jönsson, A., Nellgård, P., and Hedner, T. Reduced Albumin Extravasation in Experimental Skin Burn Injury by D-myo-inositol-1,2,6-trisphosphate. Abstract at the twenty-second annual meeting of the American Burn Association, Las Vegas, Nevada, USA, March 27-30, 1990.
2. Cassuto, J., Jönsson, A., Tarnow, P., Nellgård, P., and Rimbäck, G. Anti-inflammation mediated effects in several acute conditions by PP 56 (D-myo-inositol-1,2,6-trisphosphate). Circ. Shock Suppl. 1: 51, 1993.
3. Arturson, G. Possible involvement of arachidonic acid metabolites in thermal trauma. In R. Dolecek, L. Brizio-Molteni, A. Molteni, and D. Traber (Eds.), Endocrinology in Thermal Trauma: Patophysiologic Mechanisms and Clinical Interpretation, pp. 238-252. Philadelphia: Lea & Febiger, 1990.
4. Tavares, I. A., Collins, P. O., and Bennett, A. Inhibition of prostanoid synthesis by human gastric mucosa. Aliment. Pharmacol. Ther. 1: 617, 1987.
5. Arturson, G. Pathophysiology of the burn wound. Ann. Chir. Gyn. 69: 178, 1980.
6. Arturson, G. Prostaglandins in human burn wound secretion. Burns 3: 112, 1977.
7. Arturson, G., Hamberg, M., and Jonsson, C.-E. Prostaglandins in human burn blister fluid. Acta Physiol. Scand. 87: 270, 1973.
8. Harms, B. A., Bodai, B. I., Smith, M., Gunther, R., Flynn, J., and Demling, R. H. Prostaglandin release and altered microvascular integrity after burn injury. J. Surg. Res. 31: 274, 1981.
9. Heggers, J. P., Loy, G. L., Robson, M. C., and DelBeccaro, E. J. Histological demonstration of prostaglandins and thromboxanes in burned tissue. J. Surg. Res. 28: 110, 1980.
10. Jonsson, C.-E., Granström, E., and Hamberg, M. Prostaglandins and thromboxanes in burn injury in man. Scand. J. Plast. Reconstr. Surg. 13: 45, 1979.
11. Ånggård, E., and Jonsson, C.-E. Efflux of prostaglandins in lymph from scalded tissue. Acta. Physiol. Scand. 81: 440, 1971.
12. 2 levels in the plasma of burned and septic burned patients. Surg. Gynecol. Obstet. 159: 210, 1984.
13. Denzlinger, C., Rapp, S., Hagmann, W., and Keppler, D. Leukotrienes as mediators in tissue trauma. Science 230: 330, 1985.
14. 4 in thermally injured patient's plasma and burn blister fluid. J. Burn Care Rehabil. 8: 189, 1987.
15. Alexander, F., Mathieson, M., Teoh, K. H. T., Huval, W. V., Lecuk, S., Valeri, R., Shepro, D., and Hechtman, H. B. Arachidonic acid metabolites mediate early burn edema. J. Trauma. 24: 709, 1984.
16. Da Costa, R., Aggarwal, S. J., Diller, K. R., and Baxter, C. R. The effects of epinephrine, ibuprofen, and tetrachlorodecaoxide on cutaneous microcirculation in thermally injured hamsters. J. Burn Care Rehabil. 13: 396, 1992.
17. Hughes, G. S., Francom, S. F., Means, L. K., Bohan, D. F., Caruana, C., and Holland, M. Synergistic effects of oral nonsteroidal drugs and topical corticosteroids in the therapy of sunburn in humans. Dermatology 184: 54, 1992.
18. Del Beccaro, E. J., Robson, M., Heggers, J. P., and Swaminathan, R. The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning. Surgery 87: 137, 1987.
19. Saranto, J. R., Rubayi, S., and Zawacki, B. E. Blisters, cooling, antithromboxanes, and healing in experimental zone-of-stasis burns. J. Trauma 23: 927, 1983.
20. Björk, J., and Arturson, G. Effect of cimetidine, hydrocortisone, superoxide dismutase and catalase on the development of oedema after thermal injury. Burns 9: 249, 1983.
21. Edvinsson, L., and Adamsson, M. Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary and uterine arteries: blockade by D-myo-inositol-1,2,6-trisphosphate. J. Cardiovasc. Pharmacol. 20: 466, 1992.
22. Ahren, B. Inhibitory effect of D-myo-inositol-1,2,6-trisphosphate (PP 56) on glucose-stimulated insulin secretion in the mouse. Neuropeptides 21: 163, 1992.
23. Carrington, A. L., Calcutt, N. A., Ettlinger, C. B., Gustafsson, T., and Tomlinson, D. R. Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP 56) on nerve conduction in streptozotocin-diabetes. Eur. J. Pharmacol. 237: 257, 1993.
24. Perry, H. M., Jr., Erlanger, M. W., Gustafsson, T. O., and Perry, E. F. Reversal of cadmium induced hypertension by D-myo-inositol-1,2,6-trisphosphate. J. Toxicol. Environ. Health 28: 151, 1989.
25. Claxson, A., Morris, C., Blake, D., Sirén, M., Halliwell, B., Gustafsson, T., Lofqvist, B., and Bergelin, I. The anti-inflammatory effects of D-myo-inositol-1,2,6-trisphosphate on animal models of inflammation. Agents Actions 29: 68, 1990.
26. Nazakawa, H., Gustafsson, T. O., Traber, L. D., Herndon, D. N., and Traber, D. L. α-trinositol decreases lung edema formation after smoke inhalation in an ovine model. J. Appl. Physiol. 76: 278, 1994.
27. Hart, F. D., and Huskisson, E. C. Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use. Drugs 27: 232, 1984.
28. Yoo, H., Fallgren, B., Lindahl, A., and Wahlestedt, C. Characterisation of specific binding sites for α-trinositol (D-myo-inositol-1,2,6-trisphosphate) in rat tissues. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 16: 55, 1994.
29. Wahlestedt, C., Reis, D. J., Yoo, H., Adamsson, M., Andersson, D., and Edvinsson, L. A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine trisphosphate (ATP). Neurosci. Lett. 143: 123, 1992.
30. Samuelsson, B., Goldyne, M., Granström, E., et al. Prostaglandins and thromboxanes. Annu. Rev. Biochem. 47: 977, 1978.
31. Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., and Sherhan, C. N. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237: 1171, 1987.